|
Volumn 3, Issue 9, 2015, Pages 680-681
|
Mortality and metformin use in patients with advanced chronic kidney disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN A1C;
METFORMIN;
ANTIDIABETIC AGENT;
CHRONIC KIDNEY DISEASE;
COMORBIDITY;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
GLOMERULUS FILTRATION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
KIDNEY FAILURE;
KIDNEY TUBULE EXCRETION;
LACTIC ACIDOSIS;
LETTER;
MORTALITY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT DURATION;
CHRONIC KIDNEY FAILURE;
COMPLICATION;
DIABETES MELLITUS, TYPE 2;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
RENAL INSUFFICIENCY, CHRONIC;
|
EID: 84939500117
PISSN: 22138587
EISSN: 22138595
Source Type: Journal
DOI: 10.1016/S2213-8587(15)00285-5 Document Type: Letter |
Times cited : (3)
|
References (5)
|